| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Catalyst Pharmaceuticals, Inc. (CPRX) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 8 sells. CPRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 4.18M | $130.20M | - | |
| Other | 1.47M | $45.86M | - | |
| Dir | 498.8K | $15.54M | - | |
| Dir | 383.3K | $11.94M | - | |
| CEO | 281.8K | $8.78M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2022 | Denkhaus Donald A | Director | Sell | 20,000 | $15.34 | $306,800.00 | -6.3% | +14.7% | -17.5% | |
| Sep 14, 2022 | McEnany Patrick J63 | President And CEO | Sell | 1,027,611 | $15.41 | $15,832,730.93 | -10.5% | +14.7% | -17.5% | |
| Sep 14, 2022 | Coelho Philip H65 | Director | Sell | 30,000 | $15.73 | $472,000.00 | -5.5% | +14.7% | -17.5% | |
| Sep 13, 2022 | Miller Steve56 | Chief Operating Officer | Sell | 107,933 | $16.90 | $1,824,366.56 | -4.8% | +13.8% | -16.8% |